CMMB · Chemomab Therapeutics Ltd.
$1.39
-0.01 (-0.71%)
At close · Jul 24
Market Cap
$9.97M
Shares
7.33M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$9M
+35.5%
FY2025
Diluted EPS
$0.02
-88.5%
FY2025
Operating Cash Flow
-$11.13M
+27.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| $2.33M | $2.47M | $4.39M | — | — | — | — | |
| $5.83M | $11.33M | $18.38M | $16.98M | $6.33M | $3.78M | $13.3M | |
| $3.73M | $3.41M | $7.08M | $11.56M | $6.03M | $7.18M | $6.25M | |
| — | — | — | — | — | $749K | $3.35M | |
| $9.57M | $14.74M | $25.46M | $28.53M | $12.37M | $11.71M | $22.9M | |
| -$112M | -$103M | — | — | — | — | — | |
| $572K | $794K | $1.24M | $353K | — | — | — | |
| -$9M | -$13.95M | -$24.22M | -$28.18M | $12.48M | $11.61M | $27.12M | |
| $0 | $0 | $0 | -$534K | — | $0 | $306K | |
| -$9M | -$13.95M | -$24.22M | -$27.65M | -$12.48M | -$11.61M | -$27.12M | |
| — | — | — | — | — | — | $27.12M | |
| USD/shares | $0.02 | $0.16 | $0.41 | $0.48 | — | — | — |
| USD/shares | $0.02 | $0.16 | $0.41 | $0.48 | — | — | — |
| shares | 510.23M | 89.76M | 58.75M | 56.9M | 51.87M | 579.6719 | 538.22K |
| shares | 510.23M | 89.76M | 58.75M | 56.9M | 51.87M | 579.6719 | 538.22K |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.